Obtaining FDA clearance is only half the battle; without insurer coverage, patient access remains bottlenecked. This study presents real-world data pipelines proving health economic return on investment.
Analyzing medical claims from 15,000 patients revealed an average savings of $3,120 per treated individual within the first year, driven primarily by fewer inpatient psychiatric hospitalizations.
Automated reporting pipelines generate quarterly value-demonstration packets for health plan pharmacy and therapeutics (P&T) committees, safeguarding ongoing formulary inclusion.